바이오솔루션

086820KOSDAQ기초 의약물질 제조업

43.3 / 100

Reference Date: 2026-04-13

Financial Score10.0 / 40

News Sentiment15.3 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: PER raises overvaluation concerns, PBR raises overvaluation concerns. Declined 12.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BioSolution is a biotech company specializing in the research, development, and commercialization of advanced biopharmaceuticals, human tissue models, and biofusion materials based on stem cell and tissue engineering technologies. Key products include Kerahil for burn treatment and Catilife for cancer therapy, with OECD and ISO certifications enabling entry into alternative toxicity testing markets. The company also leads the clean and vegan cosmetics market through biofusion materials derived from plant stem cells and natural substances.

Number of Employees

100people

Average Salary

57.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

1025.45Industry Average 33.450.0Point

30.7x industry avg (risky)

PBR

9.14Industry Average 2.030.0Point

4.5x industry avg (risky)

ROE

0.86Industry Average -4.293.5Point

Well below industry avg

Debt Ratio

7.08Industry Average 6.612.0Point

Higher than industry avg (caution)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.7% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲6.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -11.5% (improving, 3yr)

Detailed News Sentiment

8 totalPositive 1Neutral 3Negative 0Average Sentiment Score 72.5

Neutral
바이오솔루션, 서울대병원에 '카티라이프' 공급…관절 재생치료 확대
Neutral
바커케미칼코리아, 차세대 기능성 식품 소재 원료 기술 세미나 개최
바커케미칼코리아가 차세대 기능성 식품 소재 원료 기술 세미나를 개최하고 바이오솔루션 사업부 핵심 산업 분야에 대해 설명했다는 내용은 바이오솔루션에 직접적인 영향을 미치지 않습니다.
Positive
바이오솔루션 “무릎 연골 살리는 카티라이프, 中 진출 눈앞…美 FDA와...
바이오솔루션은 자가 연골세포치료제 '카티라이프'의 중국 판매 승인이 임박했으며, 미국 FDA와 미팅 후 파트너 물색을 통해 글로벌 사업을 본격화할 계획입니다.

Detailed Momentum

52-week position6.0Point

52w upper range (69%)

Current 11,280Won52-week high 12,95052-week low 7,390

1-month return1.0Point

1m -12.01% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral기업설명회(IR)개최2026-04-08
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
Neutral정기주주총회결과2026-03-27
Neutral감사보고서제출2026-03-19
Neutral사업보고서 (2025.12)2026-03-19